<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW, NOARCHIVE" />
<meta name="dc.language" content="eng" />
<meta name="dc.title" content="Morgan v. Toronto (City) (September 5, 2008)" />	
<meta name="dc.date.created" content="2008-09-05" />
<meta name="dc.date.modified" content="2008-09-05" />
<title>Morgan v. Toronto (City) (September 5, 2008)</title>
<style>
<!--
h1
	{text-align:center;
	page-break-after:avoid;
	font-size:15.0pt;
	font-family:"Times New Roman";
	font-weight:normal;}
h2
	{text-align:center;
	line-height:200%;
	page-break-after:avoid;
	font-size:15.0pt;
	font-family:"Times New Roman";}
h3
	{text-align:justify;
	font-size:13.0pt;
	font-family:"Times New Roman";}
h4
	{text-align:justify;
	line-height:200%;
	page-break-after:avoid;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{text-align:justify;
	tab-stops:center 216.0pt right 432.0pt;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{text-align:justify;
	tab-stops:center 216.0pt right 432.0pt;
	font-size:13.0pt;
	font-family:"Times New Roman";}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{text-align:justify;
	font-size:8.0pt;
	font-family:Tahoma;}
p.Doubleindent-quote, li.Doubleindent-quote, div.Doubleindent-quote
	{text-align:justify;
	tab-stops:108.0pt;
	margin-left: 10%; 
	margin-right: 10%;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.DOCKETINFOFIELD, li.DOCKETINFOFIELD, div.DOCKETINFOFIELD
	{text-align:right;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.Double-indent-subquote, li.Double-indent-subquote, div.Double-indent-subquote
	{text-align:justify;
	tab-stops:144.0pt;
	font-size:13.0pt;
	margin-left: 15%; 
	margin-right: 15%;
	font-family:"Times New Roman";}
p.headingNUMBER, li.headingNUMBER, div.headingNUMBER
	{text-align:justify;
	text-indent:0cm;
	line-height:200%;
	tab-stops:36.0pt;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.COURTOFAPPEAL, li.COURTOFAPPEAL, div.COURTOFAPPEAL
	{text-align:center;
	font-size:15.0pt;
	font-family:"Times New Roman";}
p.StyleofCause, li.StyleofCause, div.StyleofCause
	{text-align:center;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.ParaNO, li.ParaNO, div.ParaNO
	{text-align:justify;
	line-height:200%;
	tab-stops:36.0pt;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.RespondentAppellant, li.RespondentAppellant, div.RespondentAppellant
	{text-align:right;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.Versus, li.Versus, div.Versus
	{text-align:center;
	font-size:13.0pt;
	font-family:"Times New Roman";}
p.Party, li.Party, div.Party
	{font-size:13.0pt;
	font-family:"Times New Roman";}
p.Panel, li.Panel, div.Panel
	{text-align:center;
	font-size:13.0pt;
	font-family:"Times New \(W1\)";}
ol
	{ul
	{-->
</style>
</head>
<body bgcolor="#FFFFFF" vlink=purple lang=EN-CA>
<div class=Section1>
  <table border=0 align="center" cellpadding=0 cellspacing=10>
    <tr>
      <td width=638 valign=top><p class=DOCKETINFOFIELD>CITATION:&nbsp;Morgan&nbsp;v.&nbsp;
          <st1:City w:st="on">
          <st1:place
   w:st="on">
          Toronto (City),&nbsp;2008 ONCA 603</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=DOCKETINFOFIELD>DATE: 20080905</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=DOCKETINFOFIELD>DOCKET: C46442</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=COURTOFAPPEAL>COURT OF APPEAL FOR ONTARIO</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Panel>Winkler C.J.O., MacFarland and
          Epstein JJ.A.</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p>BETWEEN:</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=StyleofCause>Lucia Morgan</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=RespondentAppellant>Plaintiff (Appellant)</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Versus>and</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=StyleofCause>The Corporation of the City
          of
          <st1:City w:st="on">
          <st1:place
   w:st="on">
          Toronto</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=RespondentAppellant>Defendant (Respondent)</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party>Richard E. Anka for the appellant</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party>Peter Manderville and Belinda Bain
          for the respondent</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party>Heard and released
      orally: September 3, 2008</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party>On appeal from the judgment of
          Justice Mary A. Sanderson of the Superior Court of Justice dated November
          27, 2006.</p></td>
    </tr>
    <tr>
      <td width=638 valign=top><p class=Party align=center style='text-align:center'>ENDORSEMENT</p></td>
    </tr>
  </table>
  <p class=headingNUMBER style='line-height:normal'>[1]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>We
    agree with the trial judge that the standard to be applied to the respondent
    (“Jones”) was that of a prudent and diligent nurse in the same circumstances.  Jones
    had a duty to disclose all known material risks associated with the vaccine,
    Energix B.</p>
  <p class=headingNUMBER style='line-height:normal'>[2]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Against
    that background, the trial judge, in her comprehensive reasons for judgment,
    made strong findings of credibility and fact.  Counsel for the appellant
    challenges many of the key findings.  The most significant of these are:</p>
  <p class=headingNUMBER style='line-height:
normal'>(a)       In 1994, concerns about the risk of serious neurological damage
    from Energix B had not risen to a level where the risk could          properly
    be characterized as being known.</p>
  <p class=headingNUMBER style='line-height:
normal'>(b)       Even if the risk of serious neurological damage had been disclosed,
    the appellant would have opted to receive the first shot.</p>
  <p class=headingNUMBER style='line-height:
normal'>(c)       Specifically in relation to the second shot, the appellant
    did not tell Jones about experiencing flu-like symptoms after the first
    shot.</p>
  <p class=headingNUMBER style='line-height:normal'>[3]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>There
    was ample support in the evidence for each of these findings.</p>
  <p class=headingNUMBER style='line-height:normal'>[4]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>The
    finding that in 1994 the vaccine was largely regarded by medical practitioners
    as being safe was supported by the extensive medical evidence available to
    the trial judge.  This medical evidence included both literature and the
    testimony of doctors called by the appellant, including her own family doctor
    upon whom she relied.</p>
  <p class=headingNUMBER style='line-height:normal'>[5]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>The
    finding that Jones would have decided to be vaccinated even if advised of
    a possible link between the vaccine and neurological damage was supported
    by the evidence that the appellant considered that being vaccinated was a
    requirement of her highly valued new job and that the inoculation was recommended
    by her family doctor.</p>
  <p class=headingNUMBER style='line-height:normal'>[6]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>The
    finding that the appellant did not advise Jones, before Jones administered
    the second shot, that she experienced an adverse reaction to the first shot
    was amply supported by the evidence including the irrefutable evidence that
    the appellant made no connection between the vaccine shot and her flu-like
    symptoms until months after the second shot.</p>
  <p class=headingNUMBER style='line-height:normal'>[7]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>There
    are no grounds upon which this court could exercise its narrow power to interfere
    with these findings.</p>
  <p class=headingNUMBER style='line-height:normal'>[8]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>On
    these findings the trial judge’s ultimate conclusions that Jones did not
    breach the standard of care, the appellant’s written consent to the vaccination
    was informed consent and that in any event no causation could be established,
    are unassailable on appeal.</p>
  <p class=headingNUMBER style='line-height:normal'>[9]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>The
    appeal is therefore dismissed.  </p>
  <p class=headingNUMBER style='line-height:normal'>[10]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Costs
    of the appeal to the respondent fixed at $8,000 inclusive of disbursements
    and G.S.T.</p>
  <p>“Winkler C.J.O.”</p>
  <p>“J. MacFarland J.A.”</p>
  <p>“G. Epstein J.A.”</p>
</div>
</body>
</html>
